Overview
Rahul Gaikwad practices practicing medicine in Buraydah, Saudi Arabia.
Mr. Gaikwad is highly rated in 1 condition, according to our data. His clinical expertise encompasses Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma.
He is actively involved in clinical research, co-authoring 22 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Rahul N. Gaikwad
Is Rahul N. Gaikwad a top-rated expert for Oral Submucous Fibrosis?
MediFind is an objective health platform that identifies experts based on real-world data. Rahul N. Gaikwad is classified as an Advanced expert for Oral Submucous Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Rahul N. Gaikwad participate in research or clinical trials?
Yes. Rahul N. Gaikwad has published 22 articles and abstracts on conditions like Oral Submucous Fibrosis. You can view a list of Rahul N. Gaikwad's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Oral Submucous FibrosisMr. Gaikwad isAdvanced. Learn about Oral Submucous Fibrosis.
- Experienced
- Oral Squamous Cell CarcinomaMr. Gaikwad isExperienced. Learn about Oral Squamous Cell Carcinoma.